Beijing Wandong Medical Technology Co., Ltd. Class A

Beijing Wandong Medical Technology Co., Ltd. Class A

SSSE:600055
10.03
CNY
-0.08
(-0.79%)
-0.49EPS
7.45BMarket Cap
Apr 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.57
1.54
2.76
2.1
1.62
1.74
1.8
2.1
2.15
1.73
1.77
2.13
1.89
2.05
Basic EPS, GAAP
0.09
0.05
0.14
0.18
0.2
0.28
0.31
0.41
0.34
0.27
0.27
0.22
-0.32
-0.49
Free Cash Flow per Basic Share
-0.04
-0.09
-0.5
0.21
-0.24
0.06
0.1
0.92
0.14
0.26
0.27
0.25
-0.49
- -
Dividend per Share
0.03
0.03
0.08
0.06
0.11
0.05
0.1
0.05
0.13
0.11
0.12
0.13
0.13
- -
Book Value per Share
1.37
1.38
1.44
3.31
3.41
3.63
3.86
4.22
4.43
6.55
6.7
6.78
6.34
6.1
Tangible Book Value per Share
1.22
1.21
1.25
3.16
3.28
3.52
3.75
4.13
4.37
6.52
6.66
6.69
6.23
5.97
Basic Weighted Avg Shares
489
480
297
387
546
548
545
538
539
650
698
715
712
698
Sales/Revenue/Turnover
765
740
818
813
884
955
982
1,132
1,156
1,121
1,237
1,524
1,347
1,431
Operating Margin (%)
4.05
-0.67
2.98
4.79
11.57
18.05
20.58
26.43
16.61
11.97
8.11
7.51
-20.27
-25.08
Depreciation Expense
21
17
24
32
35
38
39
39
37
35
36
39
45
- -
Net Income, GAAP
44
26
40
72
109
153
169
221
183
175
189
157
-228
-345
Effective Tax Rate (%)
1.06
7.73
14.51
15.58
14.86
13.81
13.67
17.25
13.01
10.6
10.56
4.92
- -
- -
Profit Margin (%)
5.7
3.47
4.93
8.8
12.34
16.06
17.19
19.5
15.84
15.64
15.25
10.32
-16.92
-24.09
Working Capital
324
235
130
1,244
1,198
1,070
1,131
1,414
1,533
3,774
3,878
3,917
3,458
3,369
LT Debt
4
4
4
4
4
4
- -
13
14
16
11
14
16
8
Total Equity
674
678
711
1,858
1,902
2,018
2,184
2,378
2,503
4,711
4,821
4,878
4,568
4,401
Return on Invested Capital (%)
2.4
-1.48
1.27
3.04
5.37
7.93
7.94
9.74
7.54
4.82
4.04
3.24
- -
- -
Return on Capital (%)
6.15
4.1
5.7
5.47
6.26
8.06
8.25
9.82
7.62
4.96
3.92
3.24
- -
- -
Return on Common Equity (%)
6.57
3.85
5.9
5.74
6
8.05
8.33
10.1
7.83
5.01
4.05
3.32
-4.94
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
6
4
3
LT Borrowings
- -
- -
- -
LT Finance Leases
16
3
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
703
703
703
Market Capitalization
10,363
7,185
7,452

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,235
4,091
4,052
Cash, Cash Equivalents & STI
2,963
2,936
2,925
Accounts Receivable, Net
454
531
572
Inventories
525
357
275
Total Current Liabilities
784
686
683
Payables & Accruals
- -
- -
- -
ST Debt
6
4
3
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.74%
18.13%
-6.35%
Free Cash Flow
10.05%
-50.83%
-295.37%
Net Income, GAAP
-6.37%
-55.02%
-244.81%
Sales/Revenue/Turnover
5.52%
4.21%
-11.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
308
392
393
431
1,524
2025
373
470
- -
158
1,347
2026
407
468
397
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.07
0.04
0.06
0.22
2025
0.05
0.02
- -
-0.29
-0.32
2026
-0.02
-0.11
-0.07
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.13
2025
- -
- -
- -
- -
0.13
2026
- -
- -
- -
- -
- -

Company Description

CEO
Jin Song Song
Full Time Employees
1,215
Sector
Health technology
Industry
Medical specialties
Address
Building 3, Yard 9 Beijing BE China 100015
IPO Date
May 19, 1997
Business
Beijing Wandong Medical Technology Co., Ltd. engages in the research, development, manufacture, sale, and after-sales service of medical imaging equipment primarily in China with expanding global operations. The company offers digital X-ray radiography systems including panorama DR, ceiling DR, floor-mounted DR, U-arm DR, mobile DR, and vehicle-mounted DR; magnetic resonance imaging systems encompassing i_Vision 1.5T helium-free superconducting MRI, i_Open 0.5T/0.4T open MRI, and 3.0T MRI; X-ray computed tomography systems such as OpenCT and 128-slice cloud CT; digital subtraction angiography systems for vascular interventional therapy; dynamic flat-panel DRF systems for gastrointestinal and urogenital imaging; digital mammography systems; and ultrasound diagnostic equipment, providing comprehensive diagnostic solutions to hospitals, imaging centers, and medical institutions worldwide. Founded in 1955 and headquartered at Building 3, No. 9 Jiuxianqiao East Road, Chaoyang District, Beijing, China, it operates as a subsidiary of Midea Group since its 2021 acquisition and maintains R&D and manufacturing bases in Beijing and Suzhou with sales networks in over 70 countries. Recent developments include the launch of industry-first products such as full-frame DR, OpenCT, and 128-cloud CT over the past three years; strategic partnerships in Latin America with Nicaragua for public hospital equipment supply and Brazil for localized manufacturing and services; the opening of new international offices to bolster global expansion under its "4+2+4" strategy; and the commencement of operations at its Beijing R&D and manufacturing base in 2025 to advance intelligent manufacturing in high-end medical imaging.